---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-103747"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2023-09-26T23:59:59+00:00"
generated_at: "2026-06-10T08:56:21.854949+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Journey Medical regains Nasdaq compliance with stockholders' equity rule

## Summary
- Previously notified Aug 15, 2023 of non-compliance with Nasdaq minimum $2.5M stockholders' equity.
- Received $19M upfront payment from license agreement on Aug 31, 2023 to address deficiency.
- On Sep 20, 2023, Nasdaq Staff confirmed the company meets the Stockholders' Equity Requirement.
- Company remains listed on Nasdaq Capital Market; delisting risk removed.

## SEC filing metadata
- accession: 0001104659-23-103747
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2023-09-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/0001104659-23-103747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/tm2326916d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-103747
- JSON: https://secwatch.observer/filing/0001104659-23-103747.json
- Plain text: https://secwatch.observer/filing/0001104659-23-103747.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.